clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01902953 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2016-06-01 | |
P4135 | maximum age | 85 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 16 | |
P6153 | research site | Maimonides Medical Center | Q6735870 |
P580 | start time | 2013-03-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Prospective, Open-Label, Ex Vivo Comparison Study of Lymphoseek® and Vital Blue Dye (VBD) as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC) Patients' Excised Colon w/ Abdominal Lymphatic Bed |
Search more.